Zebra Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	$631K	Sell	27,110 -10,339	-28%	-$241K	3.15%	4
2022 Q4	$948K	Sell	37,449 -2,655	-7%	-$67.2K	3.32%	4
2022 Q3	$773K	Buy	40,104 +14,685	+58%	+$283K	2.94%	3
2022 Q2	$647K	Buy	25,419 +3,192	+14%	+$81.2K	1.9%	14
2022 Q1	$572K	Buy	+22,227	New	+$572K	1.31%	25